Table 3.
Postoperative Outcomes
| Variables | Overall (n = 182) | Control (n = 91) | NICT (n = 91) | P-value |
|---|---|---|---|---|
| PPCs (%) | 66 (36.3) | 24 (26.4) | 42 (46.2) | 0.009 |
| Respiratory infection (%) | 54 (29.7) | 20 (22.0) | 34 (37.4) | 0.035 |
| Respiratory failure (%) | 14 (7.7) | 7 (7.7) | 7 (7.7) | >0.999 |
| Pleural effusion (%) | 29 (15.9) | 9 (9.9) | 20 (22.0) | 0.043 |
| Atelectasis (%) | 21 (11.5) | 9 (9.9) | 12 (13.2) | 0.643 |
| Pneumothorax (%) | 4 (2.2) | 2 (2.2) | 2 (2.2) | >0.999 |
| Bronchospasm (%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | >0.999 |
| Aspiration pneumonitis (%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | >0.999 |
| Major adverse cardiac events | ||||
| Sinus tachycardia (%) | 31 (17.0) | 9 (9.9) | 22 (24.2) | 0.018 |
| Atrial fibrillation (%) | 7 (3.8) | 2 (2.2) | 5 (5.5) | >0.441 |
| Acute coronary syndrome (%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | >0.999 |
| Myocardial injury (%) | 14 (7.7) | 8 (8.8) | 6 (6.6) | 0.781 |
| Anastomotic leakage (%) | 25 (13.7) | 17 (18.7) | 8 (8.8) | 0.085 |
| Chylothorax (%) | 3 (1.6) | 0 (0.0) | 3 (3.3) | 0.244 |
| Sepsis (%) | 3 (1.6) | 1 (1.1) | 2 (2.2) | >0.999 |
Abbreviations: PPCs, postoperative pulmonary complications; NICT, neoadjuvant immunochemotherapy.